Research institute
With the goal of improving oral health for better overall physical and emotional health, Regenstrief Institute and Indiana University School of Dentistry are joining together to establish a novel dental informatics program.
Brown University and Hebrew SeniorLife leading research incubator
This modified design for the CRISPR gene editing tool could eventually improve therapies for HIV and sickle cell disease
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Artios Pharma Limited, The University of Texas MD Anderson Cancer Center and ShangPharma Innovation announce the in-licensing by Artios of a small-molecule ATR inhibitor programme, developed jointly by MD Anderson and ShangPharma.
A scientific study of African populations discovers that the beta-amyloid gene is associated with an increased risk of the most common form of glaucoma
Under the new deal, Artios Pharma licensed rights to research, develop, manufacture and commercialize products globally from a small-molecule ATR inhibitor program that was jointly developed by MD Anderson and ShangPharma.
Researchers at Sweden’s Karolinska Institutet identified 10 potential drug targets for glioblastoma and published the results in the journal Cell Reports.
A*STAR’s Institute of Bioengineering and Nanotechnology has teamed up with the Singapore Institute of Advanced Medicine Holdings Pte Ltd to explore how to better tackle nasopharyngeal carcinoma, a type of head and neck cancer, through targeted proton therapy.
They announced an exclusive license deal and research agreement to develop cord-blood derived chimeric antigen receptor-directed natural killer (CAR NK)-cell therapies.
PRESS RELEASES